Cargando…
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021
This paper presents the key outcomes of the above WHO informal consultation with global stakeholders including regulatory authorities, vaccine developers and manufacturers, academia and other international health organizations and institutions involved in the development, evaluation and use of messe...
Autores principales: | Liu, Margaret A., Zhou, Tiequn, Sheets, Rebecca L., Meyer, Heidi, Knezevic, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812800/ https://www.ncbi.nlm.nih.gov/pubmed/35001848 http://dx.doi.org/10.1080/22221751.2022.2026742 |
Ejemplares similares
-
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019
por: Sheets, Rebecca, et al.
Publicado: (2020) -
Development of mRNA Vaccines: Scientific and Regulatory Issues
por: Knezevic, Ivana, et al.
Publicado: (2021) -
Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021
por: Suliman, Sara, et al.
Publicado: (2021) -
73rd Annual Meeting of the American Academy of Neurology (AAN 2021): 17–22 April 2021
por: Pochon, Sue
Publicado: (2021) -
IPPOG Meeting at LIP, Lisbon, Portugal, 20-22 April 2017
por: Abreu, Pedro
Publicado: (2017)